Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

TechMARK movers: Puricore bounces off bottom

Wed, 02nd Feb 2011 12:58

Puricore has bounced back after the share price hit its lowest level for two years. The endoscope cleaning and food safety business has yet to publish a trading statement for 2010. Last year, it published a 2009 trading statement on the 20 January. The third quarter interim management statement was published on 8 November. Third quarter sales were 5% higher than one year before at $11.1m, with strong growth in endoscopy revenues helped by an acquisition. There was a decline in the food safety business revenue. Retailers should have decided their budgets for 2011 by nowand this will determine demand for this year.Pharma company AstraZeneca has gone ex-dividend today. The final dividend is 116.7p a share but the share price has fallen by less than the dividend payment. FTSE TechMARK - Risers Parity Group (PTY) 30.00p +8.11%Puricore (PURI) 50.50p +6.32%Pace (PIC) 204.80p +6.17%CSR (CSR) 410.00p +5.21%Torotrak (TRK) 22.75p +4.60%Oxford Biomedica (OXB) 5.80p +3.94%Microgen (MCGN) 135.50p +3.83%E2V Technologies (E2V) 114.75p +3.38%Psion (PON) 93.75p +2.46%Xaar (XAR) 239.00p +2.14%FTSE TechMARK - Fallers AEA Technology Group (AAT) 4.75p -5.00%Sepura (SEPU) 47.50p -3.06%AstraZeneca (AZN) 2,939.00p -3.05%Antisoma (ASM) 2.23p -3.04%Axis-Shield (ASD) 303.00p -2.88%Cobham (COB) 205.10p -2.05%Spectris (SXS) 1,378.00p -1.64%Kewill (KWL) 86.25p -1.43%KCOM Group (KCOM) 58.00p -1.28%Oxford Instruments (OXIG) 644.00p -0.92%

Related Shares

More News
Today 13:00

German vaccine panel endorses Astra-Sanofi's RSV shot for infants

FRANKFURT, June 27 (Reuters) - Germany's influential vaccine advisory panel said on Thursday all infants in the country should receive AstraZeneca a...

26 Jun 2024 08:40

TOP NEWS: AstraZeneca's Tagrisso plus chemo gets approval in China

(Alliance News) - AstraZeneca PLC on Wednesday celebrated the approval of Tagrisso plus chemotherapy for a cancer form in China, a day after a similar...

25 Jun 2024 09:05

TOP NEWS: AstraZeneca details mixed findings from cancer drug trials

(Alliance News) - AstraZeneca PLC on Tuesday announced a mixed bag of results for two of its leading cancer drugs Imfinzi and Tagrisso.

25 Jun 2024 07:48

LONDON BRIEFING: Mixed bag for Astra drug; Landsec ups Bluewater stake

(Alliance News) - London's FTSE 100 is set to tread water on Tuesday, with a slump for US tech shares overnight keeping a lid on enthusiasm.

25 Jun 2024 07:17

AstraZeneca posts mixed results from recent Imfinzi trials

(Sharecast News) - AstraZeneca announced contrasting results from two phase three trials involving its immunotherapy drug 'Imfinzi', or durvalumab, on...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.